Reflections on the landmark studies of beta-carotene supplementation

J Natl Cancer Inst. 2004 Dec 1;96(23):1729-31. doi: 10.1093/jnci/djh344.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Anticarcinogenic Agents / administration & dosage*
  • Anticarcinogenic Agents / adverse effects
  • Antioxidants / administration & dosage*
  • Antioxidants / adverse effects
  • Carcinogens / administration & dosage
  • Carcinogens / adverse effects*
  • Cardiovascular Diseases / mortality
  • Clinical Trials as Topic
  • Dietary Supplements
  • Disease Models, Animal
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Lung / drug effects
  • Lung / metabolism
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / epidemiology*
  • Lung Neoplasms / etiology
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / prevention & control
  • Male
  • Oxidants / administration & dosage
  • Oxidants / adverse effects*
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects
  • United States / epidemiology
  • beta Carotene / administration & dosage*
  • beta Carotene / adverse effects*

Substances

  • Anticarcinogenic Agents
  • Antioxidants
  • Carcinogens
  • Oxidants
  • beta Carotene